BR9307182A - Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides - Google Patents

Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides

Info

Publication number
BR9307182A
BR9307182A BR9307182A BR9307182A BR9307182A BR 9307182 A BR9307182 A BR 9307182A BR 9307182 A BR9307182 A BR 9307182A BR 9307182 A BR9307182 A BR 9307182A BR 9307182 A BR9307182 A BR 9307182A
Authority
BR
Brazil
Prior art keywords
oxindol
carboxamides
substituted
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
BR9307182A
Other languages
Portuguese (pt)
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9307182A publication Critical patent/BR9307182A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
BR9307182A 1992-10-07 1993-09-02 Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides BR9307182A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07
PCT/US1993/008063 WO1994007488A1 (en) 1992-10-07 1993-09-02 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BR9307182A true BR9307182A (en) 1999-03-30

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307182A BR9307182A (en) 1992-10-07 1993-09-02 Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387A (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
UA42739C2 (en) * 1995-04-24 2001-11-15 Пфайзер Інк. Method of inhibition of the photodisintegration of pharmaceutical active compounds, tablet and capsule, containing thereof
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
DE69216642T2 (en) * 1992-01-13 1997-05-07 Pfizer METHOD FOR PRODUCING TABLETS WITH HIGH STRENGTH

Also Published As

Publication number Publication date
MY109680A (en) 1997-04-30
MX9306222A (en) 1994-04-29
JPH07507809A (en) 1995-08-31
EG20289A (en) 1998-07-30
RU2119353C1 (en) 1998-09-27
CZ282702B6 (en) 1997-09-17
NO951350D0 (en) 1995-04-06
EP0662831A1 (en) 1995-07-19
JP2721042B2 (en) 1998-03-04
TW438798B (en) 2001-06-07
WO1994007488A1 (en) 1994-04-14
IL107122A (en) 1998-08-16
CA2146448A1 (en) 1994-04-14
FI934387A (en) 1994-04-08
AU676200B2 (en) 1997-03-06
ZA937405B (en) 1995-04-06
KR950703338A (en) 1995-09-20
CN1089138A (en) 1994-07-13
NO951350L (en) 1995-06-06
CZ87895A3 (en) 1995-10-18
HUT68533A (en) 1995-04-27
FI934387A0 (en) 1993-10-06
PL174170B1 (en) 1998-06-30
NZ256164A (en) 1997-03-24
PL308307A1 (en) 1995-07-24
HU9302821D0 (en) 1993-12-28
AU4839293A (en) 1994-04-26
IL107122A0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
CY2005007I2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DARIFENACINE
ID18663A (en) COMPOSITION OF PHARMACEUTICAL PLATED PHARMACEUTICALS
BR1100824A (en) Pharmaceutical composition and composition
IS4706A (en) pharmaceutical compositions
BR9403948A (en) Composition of matter
BR9403946A (en) Composition of matter
NO20004345D0 (en) Pharmaceutical composition
FI944832A0 (en) Pharmaceutical composition
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
FI930882A (en) PHARMACEUTICAL FORM
ITMI932540A0 (en) PHARMACEUTICAL COMPOSITION
ITRM920349A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6
FI931251A (en) PHARMACEUTICAL FORM
LV11727A (en) Pharmaceutical composition
EE9900206A (en) Pharmaceutical compositions containing N-sulfonylindoline derivatives
IT1290797B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI973280A (en) Pharmaceutical composition
BR9307182A (en) Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides
LV10579A (en) Pharmaceutical composition
FI962738A0 (en) Pharmaceutical compositions
BR9605777A (en) Pharmaceutical composition
BR9605131A (en) Pharmaceutical composition
ITMI922581A0 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal